retatrutide mechanism trials ADA 2026: Revolution Retatrutide Research Guide: What the

The Danish drugmaker GLP-1 business generated 35.4% less revenue than Eli Lillys in the first quarter, according to financial results for the first three months of the year.

Aging is the strongest risk factor for many chronic diseases, including frailty and neurodegenerative conditions

Patients on GLP-1 injections can lose 15 to 20 percent of their body weight over 12 to 18 months

Conversely, this trend heralds a potential boom for producers of health-oriented products like protein shakes and meal replacements, indicating a realignment of consumer preferences towards weight-management foods

Lizzo Weight Loss: Did Ozempic play a role in her transformation

If you are pregnant or lactating, taking medication or have a medical condition, consult your healthcare practitioner before use